Hepcidin Levels and Pathological Characteristics in Children with Fatty Liver Disease

키워드

참고문헌 (39)

1. American Gastroenterological Association, "American Gastroenterological Association medical position statement : nonalcoholic fatty liver disease", Gastroenterology, 123, pp.1702~1704 (2002)
2. Neuschwander-Tetri BA, "Nonalcoholic steatohepatitis : summary of an AASLD single topic conference", Hepatology, 37, pp.1202~1219 (2003)
3. Adams LA, "The natural history of nonalcoholic fatty liver disease : a population-based cohort study", Gastroenterology, 129, pp.113~121 (2005)
4. Eguchi Y, "JSG-NAFLD. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study", J Gastroenterol, 47, pp.586~595 (2012)
5. Moran JR, "Steatohepatitis in obese children : a cause of chronic liver dysfunction", Am J Gastroenterol, 78, pp.374~377 (1983)
6. Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease : practice guidance from the American Association for the Study of Liver Diseases", Hepatology, 67, pp.328~357 (2018)
7. Anderson EL, "The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis", PLoS One, 10, pp.e0140908~ (2015)
8. Schwimmer JB, "Prevalence of fatty liver in children and adolescents", Pediatrics, 118, pp.1388~1393 (2006)
9. Tominaga K, "Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey", Dig Dis Sci, 40, pp.2002~2009 (1995)
10. Park HS, "Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents", Am J Clin Nutr, 82, pp.1046~1051 (2005)
11. Milic S, "The role of iron and iron overload in chronic liver disease", Med Sci Monit, 22, pp.2144~2151 (2016)
12. Zhao N, "Iron regulation by hepcidin", J Clin Invest, 123, pp.2337~2343 (2013)
13. Ramos E, "Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis", Blood, 120, pp.3829~3836 (2012)
14. Ahmed U, "Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis", World J Gastroenterol, 18, pp.4651~4658 (2012)
15. Messner DJ, "Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes", Dig Dis Sci, 58, pp.1899~1908 (2013)
16. Nelson JE, "Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease", Hepatology, 53, pp.448~457 (2011)
17. Chalasani N, "The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association", Am J Gastroenterol, 107, pp.811~826 (2012)
18. Matteoni CA, "Nonalcoholic fatty liver disease : a spectrum of clinical and pathological severity", Gastroenterology, 116, pp.1413~1419 (1999)
19. Kleiner DE, "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", Hepatology, 41, pp.1313~1321 (2005)
20. Brunt EM, "Nonalcoholic steatohepatitis : a proposal for grading and staging the histological lesions", Am J Gastroenterol, 94, pp.2467~2474 (1999)
21. Park CH, "Hepcidin, a urinary antimicrobial peptide synthesized in the liver", J Biol Chem, 276, pp.7806~7810 (2001)
22. Leong WI, "Hepcidin, the recently identified peptide that appears to regulate iron absorption", J Nutr, 134, pp.1~4 (2004)
23. Vuppalanchi R, "Serum hepcidin levels are associated with obesity but not liver disease", Obesity(Silver Spring), 22, pp.836~841 (2014)
24. Cakir M, "Hepcidin levels in children with chronic liver disease", Saudi J Gastroenterol, 21, pp.300~305 (2015)
25. Takahashi Y, "Histopathological characteristics of nonalcoholic fatty liver disease in children : comparison with adult cases", Hepatol Res, 41, pp.1066~1074 (2011)
26. Schwimmer JB, "Histopathology of pediatric nonalcoholic fatty liver disease", Hepatology, 42, pp.641~649 (2005)
27. Lee P, "Regulation of hepcidin transcription by interleukin-1 and interleukin-6", Proc Natl Acad Sci U S A, 102, pp.1906~1910 (2005)
28. Tomosugi N, "The discovering of hepcidin and following develop", Nihon Naika Gakkai Zasshi, 99, pp.1180~1187 (2010)
29. Gardenghi S, "Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus", Blood, 123, pp.1137~1145 (2014)
30. Verga Falzacappa MV, "STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation", Blood, 109, pp.353~358 (2007)
31. Datz C, "Iron homeostasis in the metabolic syndrome", Eur J Clin Invest, 43, pp.215~224 (2013)
32. Chung B, "Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells", J Nutr, 137, pp.2366~2370 (2007)
33. Aigner E, "Pathways underlying iron accumulation in human nonalcoholic fatty liver disease", Am J Clin Nutr, 87, pp.1374~1383 (2008)
34. Barisani D, "Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload", J Hepatol, 49, pp.123~133 (2008)
35. Aigner E, "Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver", World J Hepatol, 7, pp.177~188 (2015)
36. Rockey DC, "Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing", J Clin Invest, 98, pp.1381~1388 (1996)
37. Han CY, "Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt", Nat Commun, 7, pp.13817~ (2016)
38. Mitsuyoshi H, "Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease", Hepatol Res, 39, pp.366~373 (2009)
39. Bekri S, "Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH", Gastroenterology, 131, pp.788~796 (2006)

관련 논문AI추천